SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

IMMUDYNE INC (IMMD)

IMMD RSS Feed
Add IMMD Price Alert      Hide Sticky   Hide Intro
Moderator: Suvorov
Search This Board: 
Last Post: 5/26/2017 5:32:30 PM - Followers: 51 - Board type: Free - Posts Today: 0


 

IMMUDYNE, INC. (OTCQB: IMMD)
 

Immudyne, Inc. (OTCQB: IMMD) is a science-based wellness & healthcare company. Immudyne manufactures and sells clinically researched, doctor-recommended, yeast beta-1, 3 / 1, 6-D-glucan dietary supplements and topical skin lines.

 

PuraCere: Empower Your Immune Health

Your immune system controls your skin’s health and appearance. From regeneration and protection, to clearing of scars and acne. Activated, topical immune cells heal microscopic wounds, fight against infection, regenerate your skin, and counteract the damage from UV-ray exposure, environmental toxins, and the aging process.

PURACERETM is a naturally powerful immune support supplement. Through a proprietary process, PURACERE is extracted from Saccharomyces cerevisiae producing the purist yeast beta-1, 3 / 1, 6-D-glucan available. Hundreds of clinical studies confirm that yeast beta-1, 3 / 1, 6-D-glucans are powerful immunomodulators.

 

Products: iNR Wellness,  iNR Wellness MD,  iNR Strength,  NAYAD Serum

iNR Wellness MD is a nutritional supplement that naturally empowers your immune system with PURACERE™, IP-6, and a vitamin C complex. PURACERE is a naturally powerful immune support supplement and clinically proven to provide immune health benefits. This is why iNR Wellness MD is recommended by doctors and medical experts worldwide.

iNR STRENGTH is a nutritional supplement that naturally supports the immune system with PURACERE™ and antioxidants. PURACERE is a naturally powerful immune support supplement and clinically proven to provide immune health benefits. iNR Strength also contains the antioxidants riboflavin and thiamine, to help support energy conversion into lean muscle. This is why iNR Strength is recommended by health and wellness experts worldwide.

NAYAD Rejuvenating Serum

NAYAD is an ultrapure, topical beta-1,3/1,6-D-glucan. NAYAD is a naturally derived skincare solution that has been clinically proven to provide powerful anti-aging results. NAYAD stimulates collagen production and natural cell renewal. Scientific studies have shown that NAYAD directly connects with and activates Langerhans cells. Langerhans cells are topical immune cells. When activated, they heal microscopic wounds, fight against infection, regenerate your skin, and counteract the damage from UV-ray exposure, environmental toxins, and the aging process.

 

Management

Anthony G. Bruzzese, MD, Chairman
Mark McLaughlin, President and CEO
Sven Rohmann, MD, PhD, Global Chief Medical Officer
Joseph V. DiTrolio, MD, Chief Medical Officer, US
John Strawn, Esq., Legal


Company Ticker:    IMMD

# Shares Outstanding:    30 MM

No Debt

Average Daily Volume:    38,000

52 week range:    $0.05 – $0.41

S.E.C. Counsel: Kane Kessler 

Auditor: PKF O’Connor Davies

For further information, please contact: Immudyne, Inc.

Mark McLaughlin President & CEO

+1-914-714-8901

MarkMcL@immudyne.com

 

 

 

The Daily View



The Weekly View






 

Moderator's Disclaimer - This board is for (IMMD) discussion purposes only and is in no way a recommendation to buy or sell. Any investment decisions should be based on your own due diligence and decision. You are solely responsible for your choices to buy or sell.

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IMMD
Current Price
Volume:
Bid Ask Day's Range
IMMD News: Annual Report (10-k) 05/24/2017 06:05:33 AM
IMMD News: ImmuDyne, Inc. Announces Annual Filing Update 04/17/2017 04:30:00 PM
IMMD News: Notification That Annual Report Will Be Submitted Late (nt 10-k) 03/31/2017 09:02:03 AM
IMMD News: ImmuDyne Announces Completion of Shapiro MD Formulation Work and Update on Launch 03/23/2017 08:30:00 AM
IMMD News: Amended Current Report Filing (8-k/a) 03/08/2017 09:46:28 AM
PostSubject
#2686   If this formula even works half azz we puffadder 05/26/17 05:32:30 PM
#2685   I agree.. need an update. manfromjax 05/26/17 01:23:14 PM
#2684   Need an update on Shapiro MD puffadder 05/26/17 11:26:06 AM
#2683   That's a lot of bad karma there puffadder 05/26/17 11:13:48 AM
#2682   You need to take a powerful 'stress pill',Hap. Suvorov 05/26/17 10:21:02 AM
#2681   Andrew Currah, you are a liar, a stock Happy Investor 05/26/17 09:19:48 AM
#2680   Day after 10K, morning volume 800 shares IMMD. SuzanM 05/25/17 11:48:26 AM
#2679   Hap, the idea of being 'objective' is to Suvorov 05/25/17 10:36:39 AM
#2678   The stop was not removed until today. The Happy Investor 05/25/17 10:07:27 AM
#2677   I am praising IMMD for objective reasons. I Happy Investor 05/25/17 10:00:46 AM
#2676   Topical market is $3 bil worldwide - not puffadder 05/25/17 09:16:02 AM
#2675   Not sure but here's Amazon link - puffadder 05/25/17 09:14:24 AM
#2674   Website is looking nice, wonder what they are Rdy1 05/25/17 08:53:40 AM
#2673   Very nice looking website. manfromjax 05/25/17 08:51:47 AM
#2672   Shapiro MD web site updated and on Amazon puffadder 05/25/17 06:16:05 AM
#2671   I found IMMD in March, lol. Waited to Maniana 05/24/17 05:00:59 PM
#2670   Well, my golden rule is always sell half manfromjax 05/24/17 04:40:24 PM
#2669   True start up - next 2 Q's puffadder 05/24/17 04:27:07 PM
#2668   I agree;however, even insiders get it wrong sometimes.... Suvorov 05/24/17 04:25:15 PM
#2667   Insider action/lending is quite impressive and telling imo puffadder 05/24/17 04:22:55 PM
#2666   "Waiting for $.57 is just plain dumb!" Yes, Maniana 05/24/17 04:16:39 PM
#2665   Time will tell. Suvorov 05/24/17 04:15:33 PM
#2664   I know nothing about Suvorov, and don't care Maniana 05/24/17 04:13:02 PM
#2663   Judging from today's reaction IMMD is going nowhere. Maniana 05/24/17 04:02:17 PM
#2662   "Hopefully we see a PR on Shapiro MD Maniana 05/24/17 04:00:11 PM
#2661   I never understand why people wait a year Maniana 05/24/17 03:57:39 PM
#2660   So that bitter, inaccurate posters like yourself can Suvorov 05/24/17 03:23:51 PM
#2659   The charts are setting up and are turning Happy Investor 05/24/17 03:20:39 PM
#2658   Well, there was nothing earth shattering in the Happy Investor 05/24/17 03:08:35 PM
#2657   No, sleazy people like you need to be Happy Investor 05/24/17 03:04:21 PM
#2656   You have been demonstrated to be wrong. Happy Investor 05/24/17 03:02:48 PM
#2655   The STOP sign will be taken off, the Suvorov 05/24/17 02:53:42 PM
#2654   Stop sign up until tomorrow puffadder 05/24/17 01:43:52 PM
#2653   Hopefully we see a PR on Shapiro MD puffadder 05/24/17 01:34:18 PM
#2652   What was it all about, Alfie? manfromjax 05/24/17 12:56:57 PM
#2651   I see Happy when you run out of Suvorov 05/24/17 10:11:13 AM
#2650   Good luck, pmunch, on your long position Suvorov 05/24/17 10:01:32 AM
#2649   Happy, you can't even write in proper English: Suvorov 05/24/17 09:58:17 AM
#2648   There were probably many accounting issues which were Happy Investor 05/24/17 09:52:12 AM
#2647   It is indeed rare to see company executives Happy Investor 05/24/17 09:50:06 AM
#2646   Right. AND this could be impressive. Happy Investor 05/24/17 09:47:54 AM
#2645   Take aways from the 10K: Happy Investor 05/24/17 09:46:46 AM
#2644   Added IMMD today, cheap here . Thin pmunch 05/24/17 09:45:25 AM
#2643   Shapiro MD impact gonna be huge puffadder 05/24/17 09:42:59 AM
#2642   No one wants to advice of someone with Happy Investor 05/24/17 09:35:56 AM
#2641   $128k in audit fees - no wonder this puffadder 05/24/17 08:34:25 AM
#2640   IMMD's filings were professionally done and I am Suvorov 05/24/17 07:48:56 AM
#2639   Results do not include Shapiro MD revenues which puffadder 05/24/17 06:35:05 AM
#2638   Insiders own 46% of OS stock with incentives that puffadder 05/24/17 06:21:21 AM
#2637   10k filed $5.2 mil sales for 2016 as puffadder 05/24/17 06:19:07 AM
PostSubject